Sells infection-prevention products and equipment, and provides related services, to healthcare providers, medical device makers and pharmaceutical manufacturers.
10-K for FY2026, filed May 29, 2026STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP…View ↗
Description of Business. Our Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile…View ↗
Description of Business. Our AST segment supports medical device and pharmaceutical manufacturers through a global network of contract…View ↗
Description of Business. Our Life Sciences segment provides a comprehensive offering of products and services designed to support…View ↗
Customers buy products that STERIS delivers by shipment or, for some equipment, after installation is complete. Customers pay for services when work is completed; outsourced reprocessing and maintenance agreements are paid over their terms.
10-K for FY2026, filed May 29, 2026Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a…View ↗
Within our Healthcare and Life Sciences segments, Service revenues include revenues generated from parts and labor associated with the…View ↗
We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and…View ↗
Within our AST segment, Service revenues include contract sterilization and laboratory services, as well as service support for our…View ↗
10-K for FY2026, filed May 29, 2026
FY2026 revenue by product or service ↗$5.9B
10-K for FY2026, filed May 29, 2026
$5.9B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2026, filed May 29, 2026 |
52%
FY2023: 52%
|
Product, FY2026
$3.1B Sources
|
Sold outright |
|
Service
Mix
10-K for FY2026, filed May 29, 2026 |
48%
FY2023: 48%
|
Service, FY2026
$2.9B Sources
|
Mix |
Healthcare providers buy equipment, consumables and services; medical device and pharmaceutical manufacturers buy sterilization, testing and equipment. Customers buy through dealers, distributors or group purchasing organizations as well as by purchase orders and direct agreements.
10-K for FY2026, filed May 29, 2026Description of Business. Our Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile…View ↗
Description of Business. Our AST segment supports medical device and pharmaceutical manufacturers through a global network of contract…View ↗
Description of Business. Our Life Sciences segment provides a comprehensive offering of products and services designed to support…View ↗
Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a…View ↗
Within our Healthcare and Life Sciences segments, Service revenues include revenues generated from parts and labor associated with the…View ↗
Within our AST segment, Service revenues include contract sterilization and laboratory services, as well as service support for our…View ↗
Yes. It kept 13 cents of every revenue dollar as net income in FY2026 and turned 16 cents into free cash flow.
10-Q for Q2 FY2027, filed Nov 5, 2026
$213.7MView ↗
10-Q for Q2 FY2027, filed Nov 5, 2026
Open tableView ↗
8-K, filed Nov 4, 2026
The Company is updating its prior outlook for revenue and earnings for fiscal 2027. Expectations for consolidated revenue growth are…View ↗
8-K, filed Oct 13, 2026
On October 11, 2026, STERIS Corporation (“Purchaser”), a wholly owned subsidiary of STERIS plc (“STERIS” or the “Company”), entered into a…View ↗
Growing. Revenue grew 41% in 4 years, from $4.2B in FY2022 to $5.9B in FY2026, about 9% a year.
Dental divestiture
The latest report no longer includes the Dental segment, following its sale; the older report described dental instruments, infection-prevention products and instrument-management systems for dental practitioners and schools.
10-K for FY2023, filed May 26, 2023 10-K for FY2026, filed May 29, 2026
AST offering
The older report described AST mainly as a contract sterilization and testing provider; the latest report also describes integrated sterilization equipment and control systems as part of its offering.
10-K for FY2023, filed May 26, 2023 10-K for FY2026, filed May 29, 2026
Competes with 3M, Baxter, Boston Scientific, Belimed, Ecolab, Fortive, Getinge, Karl Storz, Olympus, Ruhof, SteelCo, Stryker, Skytron, Wassenburg, BBraun, Pentax, Sterigenics, Contec, Fedegari, and Stilmas
10-K for FY2026, filed May 29, 2026Competition. We compete with a number of large companies that have significant product portfolios and global reach, as well as a number of…View ↗
Loading...